The excess number of patients who develop an adverse outcome if they had an abnormal test compared with those who had a normal test, per 100 patients tested. RR: The relative risk of an adverse event following an abnormal test result compared with a normal test result RRR: The relative risk ratio for all studies, comparing the prognostic ability of a test in predicting an adverse event following an abnormal test result compared with coronary angiography. This was obtained from a meta-regression model including the variable test type, weighted by inverse variance, with a 0. 
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Risk difference (RD) of cardiovascular mortality after an abnormal test result compared with a normal result
